Senseonics Holdings, Inc. (SENS)
Largest Insider Buys in Sector
SENS Stock Price History Chart
SENS Stock Performance
About Senseonics Holdings, Inc.
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It …
Insider Activity of Senseonics Holdings, Inc.
Over the last 12 months, insiders at Senseonics Holdings, Inc. have bought $0 and sold $0 worth of Senseonics Holdings, Inc. stock.
On average, over the past 5 years, insiders at Senseonics Holdings, Inc. have bought $162,000 and sold $15.1M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 300,000 shares for transaction amount of $162,000 was made by ROEDER DOUGLAS A (director) on 2023‑08‑30.
List of Insider Buy and Sell Transactions, Senseonics Holdings, Inc.
| 2023-09-07 | Sale | director | 30,889 0.0062% | $0.61 | $18,842 | -13.28% | ||
| 2023-08-30 | director | 300,000 0.0619% | $0.54 | $162,000 | -0.20% | |||
| 2022-08-04 | Sale | Chief Operating Officer | 50,000 0.0103% | $1.97 | $98,500 | -47.78% | ||
| 2022-03-11 | Sale | 63,553 0.014% | $1.65 | $104,862 | -28.35% | |||
| 2022-02-11 | Sale | President and CEO | 464,390 0.1035% | $2.46 | $1.14M | -50.41% | ||
| 2022-02-11 | Sale | Chief Operating Officer | 150,197 0.0335% | $2.46 | $369,485 | -50.41% | ||
| 2022-02-11 | Sale | Chief Medical Officer | 163,870 0.0365% | $2.46 | $403,120 | -50.41% | ||
| 2022-02-11 | Sale | GC & Corp. Development Advisor | 143,126 0.0319% | $2.46 | $352,090 | -50.41% | ||
| 2022-02-11 | Sale | VP Global Sales and Marketing | 105,760 0.0236% | $2.46 | $260,170 | -50.41% | ||
| 2022-02-11 | Sale | Chief Financial Officer | 72,873 0.0162% | $2.46 | $179,268 | -50.41% | ||
| 2021-12-06 | Sale | director | 273,076 0.0568% | $2.53 | $690,882 | -43.77% | ||
| 2021-11-16 | Sale | Chief Operating Officer | 200,000 0.0443% | $3.70 | $740,000 | -56.27% | ||
| 2021-11-16 | Sale | Chief Medical Officer | 41,996 0.0093% | $3.70 | $155,385 | -56.27% | ||
| 2021-08-25 | Sale | director | 431,494 0.0912% | $3.50 | $1.51M | -45.03% | ||
| 2021-08-24 | Sale | director | 250,684 0.0561% | $3.65 | $914,997 | -43.03% | ||
| 2021-06-14 | Sale | Chief Operating Officer | 100,000 0.0143% | $2.45 | $245,000 | -27.27% | ||
| 2021-06-11 | Sale | Chief Medical Officer | 125,256 0.0289% | $4.00 | $501,024 | -27.56% | ||
| 2021-06-10 | Sale | President and CEO | 761,420 0.1008% | $2.07 | $1.58M | -19.61% | ||
| 2021-06-10 | Sale | Chief Operating Officer | 37,732 0.0085% | $3.51 | $132,439 | -19.61% | ||
| 2021-06-09 | Sale | Chief Operating Officer | 12,268 0.0019% | $2.02 | $24,781 | -3.91% |
Insider Historical Profitability
| BARRETT M JAMES | 21911183 3.6973% | $0.32 | 2 | 0 | +55.39% | |
| NEW ENTERPRISE ASSOCIATES 10 L P | 10 percent owner | 19476414 3.2865% | $0.32 | 2 | 23 | +55.39% |
| Delphi Management Partners VIII, L.L.C. | 10 percent owner | 11237221 1.8962% | $0.32 | 1 | 0 | +11.5% |
| NEW ENTERPRISE ASSOCIATES 9 L P | 10 percent owner | 8949292 1.5101% | $0.32 | 1 | 0 | +11.5% |
| Goodnow Timothy T | President and CEO | 4737786 0.7995% | $0.32 | 1 | 4 | <0.0001% |
Institutional Investor Ownership
| The Vanguard Group | $11.96M | 4.24 | 22.53M | +0.7% | +$82,700.24 | <0.0001 | |
| BlackRock | $6.32M | 2.24 | 11.91M | -2.07% | -$133,783.04 | <0.0001 | |
| Masters Capital Management, LLC | $3.72M | 1.32 | 7M | 0% | +$0 | 0.7 | |
| Geode Capital Management | $2.98M | 1.06 | 5.61M | +3.79% | +$108,908.83 | <0.0001 | |
| Charles Schwab | $1.64M | 0.58 | 3.09M | +2.93% | +$46,736.79 | <0.0001 |